Clinical Trial Update: Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity and safety of S.Flexneriza-S.Sonnei bivalent conjugate vaccine in young children aged 3 months to 5 years for dysentery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysentery
• Dysentery Bacillary

Drugs mentioned

• S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine (S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine)

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Dysentery, Dysentery, Bacillary | Phase 2 | Status: COMPLETED